Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
News
 
Recent Executive Moves 5/17/2019
NMPA Seeks Comments on Three Draft Documents on Drug/Vaccine Trac... 5/17/2019
China Approves Pfizer's Anticancer VIZIMPRO (dacomitinib) 5/17/2019
Chinese Government Raised Healthcare Funding by CNY 84B in 2018 5/17/2019
Zai Lab Files CTA for Phase 3 Trial of Novel Anti-infective ETX25... 5/17/2019
Performance Overview of A Share-Listed Chinese MedPharm Cos 2018-... 5/16/2019
Performance of Top 15 Listed Chinese Drug Companies 2018 5/16/2019
A Birds-Eye-View of the Diabetes Drug Market of Major Provincial ... 5/16/2019
WuXi Bio Builds Integrated Manufacturing Center for Innovative Bi... (free) 5/16/2019
Cumberland and Winhealth Enter Licensing Deal for Two Injection D... 5/16/2019
NHC Requires Enhanced Reporting of Hospital Statistical Data 5/15/2019
More>>
 
Feature Articles
 
Chinese Tourists to Japan Switch from Shopping Sprees to Medical ... 5/17/2019
China Proposes Major Changes to Pharmaceutical Regulations 5/17/2019
One Min to Understand the Changes in the New Chinese Anti-Competi... 5/16/2019
Developing Opportunities In Chinese Diabetes Market 5/16/2019
China Cashes In on the Cannabis Boom 5/9/2019
Chinese Bioethicists Call for 'Reboot' of Biomedical Regulation a... 5/9/2019
Progressive Reforms Shifting the Cancer Medicine Landscape in Chi... 5/9/2019
China's Conditional Approval of Bayer's Acquisition of Monsanto: ... 5/6/2019
Chinese Hospitals Set to Sell Experimental Cell Therapies 5/3/2019
Kangmei's $4bn Accounting Error Highlights China Risk (free) 5/3/2019
China to Face Repercussions of Irrational Cost Cutting as It Gets... 5/1/2019
More>>
 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links